Table of Contents
Chapter 1. Global Multiplex Biomarker Imaging Market Executive Summary
1.1. Global Multiplex Biomarker Imaging Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Component Type
1.3.2. By Imaging Technique
1.3.3. By Application
1.3.4. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Multiplex Biomarker Imaging Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Multiplex Biomarker Imaging Market Dynamics
3.1. Market Drivers
3.1.1. Technological Advancements in Imaging Systems
3.1.2. Rising Prevalence of Complex Diseases
3.1.3. Increased Emphasis on Personalized Medicine
3.2. Market Challenges
3.2.1. High Cost of Imaging Systems
3.2.2. Regulatory and Compliance Issues
3.3. Market Opportunities
3.3.1. Growing Investment in Biomedical Research
3.3.2. Expansion of Application Areas
Chapter 4. Global Multiplex Biomarker Imaging Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Multiplex Biomarker Imaging Market Size & Forecasts by Component Type 2022-2032
5.1. Segment Dashboard
5.2. Global Multiplex Biomarker Imaging Market: Component Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Instruments
5.2.2. Software
5.2.3. Services
Chapter 6. Global Multiplex Biomarker Imaging Market Size & Forecasts by Imaging Technique 2022-2032
6.1. Segment Dashboard
6.2. Global Multiplex Biomarker Imaging Market: Imaging Technique Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.2.1. Immunohistochemistry (IHC) Assay
6.2.2. Fluorescent in Situ Hybridization (FISH) Assay
6.2.3. Tissue Microarray (TMA) Assay
Chapter 7. Global Multiplex Biomarker Imaging Market Size & Forecasts by Application 2022-2032
7.1. Segment Dashboard
7.2. Global Multiplex Biomarker Imaging Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.2.1. Research
7.2.2. Clinical Diagnostics
Chapter 8. Global Multiplex Biomarker Imaging Market Size & Forecasts by End User 2022-2032
8.1. Segment Dashboard
8.2. Global Multiplex Biomarker Imaging Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.2.1. Translational Laboratories
8.2.2. Biopharmaceutical Companies
8.2.3. Academic Institutes
Chapter 9. Global Multiplex Biomarker Imaging Market Size & Forecasts by Region 2022-2032
9.1. North America Multiplex Biomarker Imaging Market
9.1.1. U.S. Multiplex Biomarker Imaging Market
9.1.1.1. Component Type breakdown size & forecasts, 2022-2032
9.1.1.2. Imaging Technique breakdown size & forecasts, 2022-2032
9.1.1.3. Application breakdown size & forecasts, 2022-2032
9.1.1.4. End User breakdown size & forecasts, 2022-2032
9.1.2. Canada Multiplex Biomarker Imaging Market
9.2. Europe Multiplex Biomarker Imaging Market
9.2.1. UK Multiplex Biomarker Imaging Market
9.2.2. Germany Multiplex Biomarker Imaging Market
9.2.3. France Multiplex Biomarker Imaging Market
9.2.4. Spain Multiplex Biomarker Imaging Market
9.2.5. Italy Multiplex Biomarker Imaging Market
9.2.6. Rest of Europe Multiplex Biomarker Imaging Market
9.3. Asia-Pacific Multiplex Biomarker Imaging Market
9.3.1. China Multiplex Biomarker Imaging Market
9.3.2. India Multiplex Biomarker Imaging Market
9.3.3. Japan Multiplex Biomarker Imaging Market
9.3.4. Australia Multiplex Biomarker Imaging Market
9.3.5. South Korea Multiplex Biomarker Imaging Market
9.3.6. Rest of Asia Pacific Multiplex Biomarker Imaging Market
9.4. Latin America Multiplex Biomarker Imaging Market
9.4.1. Brazil Multiplex Biomarker Imaging Market
9.4.2. Mexico Multiplex Biomarker Imaging Market
9.4.3. Rest of Latin America Multiplex Biomarker Imaging Market
9.5. Middle East & Africa Multiplex Biomarker Imaging Market
9.5.1. Saudi Arabia Multiplex Biomarker Imaging Market
9.5.2. South Africa Multiplex Biomarker Imaging Market
9.5.3. Rest of Middle East & Africa Multiplex Biomarker Imaging Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. PerkinElmer Inc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Thermo Fisher Scientific, Inc.
10.3.3. Bio-Rad Laboratories, Inc.
10.3.4. Abcam plc.
10.3.5. Merck KGaA
10.3.6. Illumina Inc.
10.3.7. Leica Biosystems Nussloch GmbH
10.3.8. Ventana Medical Systems, Inc.
10.3.9. Aushon BioSystems Ltd.
10.3.10. MicroConstants, Inc.
10.3.11. ToposNomos Ltd.
10.3.12. Agilent Technologies, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes